ClearPoint Neuro (CLPT) Total Debt (2011 - 2026)

ClearPoint Neuro has disclosed Total Debt across 15 years of filings, most recently posting $49.6 million for Q1 2026.

• Total Debt for Q1 2026 came in at $49.6 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $49.6 million (changed N/A YoY), and the FY2025 annual result was $49.1 million, changed N/A from the prior year.
• Total Debt came in at $49.6 million for Q1 2026 at ClearPoint Neuro, up from $49.1 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $49.6 million in Q1 2026 to a low of $9.9 million in Q1 2022.
• The 4-year median for Total Debt is $9.9 million (2023), against an average of $19.7 million.
• Across the five-year window, Total Debt tumbled 59.82% in 2022 and climbed 0.57% in 2023, its largest moves.
• ClearPoint Neuro's Total Debt stood at $9.9 million in 2022, then advanced by 0.57% to $9.9 million in 2023, then surged by 393.29% to $49.1 million in 2025, then rose by 1.16% to $49.6 million in 2026.
• The last three Total Debt figures came in at $49.6 million (Q1 2026), $49.1 million (Q4 2025), and $29.2 million (Q3 2025), per Business Quant data.